GlassScriptPhysician profile
Nicole Squillacioti, I
NPI 1932877701
$3,199.10
in general payments reported to CMS, 2019-2025
34 companies · $716 in 2025
The $716 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $112 · 2022: $990 · 2023: $542 · 2024: $839 · 2025: $716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,097.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,097.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $425.81 | 2021-2025 | Otezla, Repatha, Repatha |
| Scilex Pharmaceuticals INC. | $397.77 | 2022-2024 | Ztlido |
| Abbvie INC. | $354.37 | 2022-2025 | |
| Novo Nordisk INC | $269.58 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Vanda Pharmaceuticals INC. | $210.04 | 2021-2023 | Hetlioz, Fanapt |
| Astrazeneca Pharmaceuticals LP | $205.70 | 2022-2025 | Airsupra, Farxiga, Breztri |
| Novartis Pharmaceuticals Corporation | $145.64 | 2022-2023 | |
| Tactile Systems Technology INC | $143.58 | 2025 | Nimbl, Flexitouch Plus |
| Merck Sharp & Dohme LLC | $102.19 | 2022-2025 | Gardasil 9, Capvaxive, Gardasil |
| Esperion Therapeutics, INC. | $98.16 | 2022-2025 | Nexletol |
| Lilly USA, LLC | $95.01 | 2022-2024 | Mounjaro |
| Lundbeck LLC | $66.15 | 2024-2025 | Rexulti |
| Medicomp INC | $62.14 | 2025 | Telepatch Cardiac Monitor |
| Alk-Abello, INC | $54.89 | 2024 | Odactra, Ragwitek, Grastek |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.55 | 2023-2025 | Jardiance |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $42.98 | 2023-2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $41.93 | 2022 | |
| Phathom Pharmaceuticals, INC. | $37.22 | 2023-2024 | Voquezna |
| Alfasigma USA, INC. | $34.85 | 2021-2022 | |
| Cmp Pharma, INC. | $33.14 | 2023 | Norliqva, Tadliq, Carospir |
| Bayer Healthcare Pharmaceuticals INC. | $32.88 | 2022 | |
| Mylan Specialty L.P. | $31.78 | 2023 | Yupelri |
| Redhill Biopharma INC. | $28.87 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $26.40 | 2023 | Nuedexta |
| Ani Pharmaceuticals, INC. | $25.82 | 2025 | Purified Cortrophin Gel |
| Astellas Pharma US INC | $25.09 | 2024 | Veozah |
| Medtronic, INC. | $24.83 | 2022 | |
| Sanofi Pasteur INC. | $23.72 | 2022 | |
| Seqirus USA INC | $23.15 | 2024 | Flucelvax, Fluad |
| Pfizer INC. | $21.76 | 2024 | |
| Avanir Pharmaceuticals, INC. | $20.70 | 2022 | |
| Vbi Vaccine (Delaware) INC. | $16.91 | 2022 | |
| Shield Therapeutics INC | $15.75 | 2025 | |
| Genentech USA, INC. | $14.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Squillacioti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.